Compounds > clopidogrel

clopidogrel and Fatty Liver

clopidogrel has been researched along with Fatty Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alper, AT; Barutca, H; Bora Şişman, S; Bozbeyoğlu, E; Çakıllı, Y; Çinier, G; Güzelburç, Ö; Şahin, S; Tekkeşin, Aİ; Velibey, Y; Yıldırımtürk, Ö1
Eskind, L; Gulati, S; Montegudo, A; Narang, T; Pierson, J; Russo, MW1

Other Studies

2 other study(ies) available for clopidogrel and Fatty Liver

ArticleYear
Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2018, Volume: 46, Issue:5

    Topics: Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Fatty Liver; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Preoperative Period; Prospective Studies; Stents; Ticlopidine; Treatment Outcome

2018
Coronary artery stents and antiplatelet therapy in patients with cirrhosis.
    Journal of clinical gastroenterology, 2012, Volume: 46, Issue:4

    Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Fatty Liver; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stents; Ticlopidine

2012